Cargando…
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challenge
The potential use of smallpox as an agent of bioterrorism has renewed interest in the development of a modern vaccine capable of replacing the standard Dryvax(®) vaccine. Vaccinia virus (ACAM2000), clonally isolated from Dryvax(®) and manufactured in cell culture, was tested for immunogenicity and p...
Autores principales: | Marriott, Kathleen A., Parkinson, Christopher V., Morefield, Samantha I., Davenport, Robert, Nichols, Richard, Monath, Thomas P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533847/ https://www.ncbi.nlm.nih.gov/pubmed/18077063 http://dx.doi.org/10.1016/j.vaccine.2007.10.063 |
Ejemplares similares
-
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense
por: Monath, Thomas P., et al.
Publicado: (2004) -
The Reemerging Condition of Vaccinia: A Case Report and Brief Review of Monkeypox and Vaccinia Vaccines
por: Ryckeley, Christian, et al.
Publicado: (2023) -
Lack of Transmission of Vaccinia Virus
por: Stark, James H., et al.
Publicado: (2006) -
Vaccinia Virus Infection in Monkeys, Brazilian Amazon
por: Abrahão, Jônatas S., et al.
Publicado: (2010) -
Is MonkeyPox the next pandemic to be dealt with?
por: Pokhrel, Amrit
Publicado: (2022)